Company overview
Basic information
Company name
Farmalita, MB
Company code
304101925
VAT code
LT100017133917
Registered address
Vilnius, Lyvių g. 53C, LT-11332
Registration date
2015-09-29
Company age: 11 y. 1 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Business and other management consultancy activities
Ownership form
Private without foreign capital
MB "Farmalita"
Company code: 304101925
Address: Vilnius, Lyvių g. 53C, LT-11332
VAT code: LT100017133917
Description
This description was generated by artificial intelligence.
Farmalita, MB (company code 304101925) is an operational private small partnership registered in 2015. It is classified as a micro company within the sector of national private non-financial companies and is owned under Lithuanian private ownership, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Governance is listed as CEO only. The company is based in Vilnius, Lyviu g. 53C, LT-11332, Vilniaus m. sav., Vilniaus apskr. Its main activity is coded N.70.20.00, Business and other management consultancy activities.
Financially, the company reported revenue of EUR 49.9K in 2025, compared with EUR 58.1K in 2024 and EUR 45.4K in 2023. Net profit reached EUR 12.7K in 2025, after EUR 16.4K in 2024 and EUR 1.8K in 2023. Profit margin was 25.4% in 2025, following 28.2% in 2024 and 3.9% in 2023. Equity increased to EUR 7.6K in 2025, while total assets reached EUR 10.3K and liabilities stood at EUR 2.7K. The latest year shows lower revenue than 2024 but continued profitability and stronger balance-sheet values than in earlier years.
Financially, the company reported revenue of EUR 49.9K in 2025, compared with EUR 58.1K in 2024 and EUR 45.4K in 2023. Net profit reached EUR 12.7K in 2025, after EUR 16.4K in 2024 and EUR 1.8K in 2023. Profit margin was 25.4% in 2025, following 28.2% in 2024 and 3.9% in 2023. Equity increased to EUR 7.6K in 2025, while total assets reached EUR 10.3K and liabilities stood at EUR 2.7K. The latest year shows lower revenue than 2024 but continued profitability and stronger balance-sheet values than in earlier years.
Download a detailed company report
Make confident decisions with all the information about Farmalita, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.